News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,403 Results
Type
Article (63072)
Company Profile (151)
Press Release (640180)
Multimedia
Podcasts (77)
Webinars (13)
Section
Business (187023)
Career Advice (2839)
Deals (34735)
Drug Delivery (115)
Drug Development (79798)
Employer Resources (165)
FDA (16308)
Job Trends (15331)
News (327490)
Policy (33014)
Tag
Academia (2877)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (90)
Alliances (47652)
ALS (94)
Alzheimer's disease (1386)
Antibody-drug conjugate (ADC) (122)
Approvals (16308)
Artificial intelligence (280)
Autoimmune disease (24)
Automation (15)
Bankruptcy (327)
Best Places to Work (12058)
BIOSECURE Act (20)
Biosimilars (115)
Biotechnology (88)
Bladder cancer (80)
Brain cancer (29)
Breast cancer (283)
Cancer (2252)
Cardiovascular disease (180)
Career advice (2406)
Career pathing (34)
CAR-T (163)
Cell therapy (447)
Cervical cancer (21)
Clinical research (64852)
Collaboration (835)
Compensation (324)
Complete response letters (22)
COVID-19 (2754)
CRISPR (45)
C-suite (261)
Cystic fibrosis (102)
Data (2198)
Decentralized trials (2)
Denatured (31)
Depression (45)
Diabetes (272)
Diagnostics (6665)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (124)
Drug pricing (117)
Drug shortages (23)
Duchenne muscular dystrophy (91)
Earnings (66641)
Editorial (39)
Employer branding (20)
Employer resources (145)
Events (112789)
Executive appointments (769)
FDA (17599)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (772)
Gene editing (111)
Generative AI (24)
Gene therapy (307)
GLP-1 (723)
Government (5005)
Grass and pollen (6)
Guidances (57)
Healthcare (20061)
Huntington's disease (21)
IgA nephropathy (26)
Immunology and inflammation (121)
Indications (30)
Infectious disease (2905)
Inflammatory bowel disease (144)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (100)
Interviews (544)
IPO (15893)
IRA (45)
Job creations (3716)
Job search strategy (2019)
Kidney cancer (10)
Labor market (32)
Layoffs (517)
Leadership (23)
Legal (7539)
Liver cancer (74)
Lung cancer (315)
Lymphoma (147)
Machine learning (7)
Management (59)
Manufacturing (303)
MASH (65)
Medical device (13778)
Medtech (13783)
Mergers & acquisitions (19408)
Metabolic disorders (694)
Multiple sclerosis (83)
NASH (17)
Neurodegenerative disease (87)
Neuropsychiatric disorders (27)
Neuroscience (1929)
NextGen: Class of 2025 (7064)
Non-profit (4945)
Now hiring (22)
Obesity (366)
Opinion (253)
Ovarian cancer (75)
Pain (91)
Pancreatic cancer (81)
Parkinson's disease (148)
Partnered (21)
Patents (239)
Patient recruitment (113)
Peanut (49)
People (60792)
Pharmaceutical (43)
Pharmacy benefit managers (20)
Phase I (20431)
Phase II (28426)
Phase III (21053)
Pipeline (1164)
Policy (154)
Postmarket research (2642)
Preclinical (8552)
Press Release (67)
Prostate cancer (107)
Psychedelics (36)
Radiopharmaceuticals (261)
Rare diseases (382)
Real estate (6248)
Recruiting (67)
Regulatory (22646)
Reports (33)
Research institute (2557)
Resumes & cover letters (421)
Rett syndrome (5)
RNA editing (4)
RSV (43)
Schizophrenia (70)
Series A (133)
Series B (87)
Service/supplier (11)
Sickle cell disease (56)
Special edition (13)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3592)
State (1)
Stomach cancer (10)
Supply chain (65)
Tariffs (34)
The Weekly (44)
Vaccines (759)
Venture capitalists (40)
Weight loss (241)
Women's health (38)
Worklife (20)
Date
Today (154)
Last 7 days (840)
Last 30 days (2610)
Last 365 days (32685)
2025 (10701)
2024 (34807)
2023 (39430)
2022 (50475)
2021 (55572)
2020 (54782)
2019 (48865)
2018 (37154)
2017 (32849)
2016 (32788)
2015 (38408)
2014 (31401)
2013 (27415)
2012 (28981)
2011 (29240)
2010 (27644)
Location
Africa (980)
Alabama (59)
Alaska (7)
Arizona (202)
Arkansas (13)
Asia (41251)
Australia (7345)
California (5859)
Canada (1984)
China (529)
Colorado (265)
Connecticut (282)
Delaware (143)
Europe (94135)
Florida (884)
Georgia (216)
Hawaii (1)
Idaho (61)
Illinois (582)
India (27)
Indiana (316)
Iowa (9)
Japan (157)
Kansas (103)
Kentucky (25)
Louisiana (11)
Maine (70)
Maryland (883)
Massachusetts (4387)
Michigan (232)
Minnesota (375)
Mississippi (2)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (62)
New Hampshire (69)
New Jersey (1716)
New Mexico (30)
New York (1721)
North Carolina (1002)
North Dakota (9)
Northern California (2544)
Ohio (203)
Oklahoma (15)
Oregon (37)
Pennsylvania (1313)
Puerto Rico (12)
Rhode Island (31)
South America (1296)
South Carolina (19)
South Dakota (1)
Southern California (2208)
Tennessee (102)
Texas (874)
United States (22648)
Utah (190)
Virginia (144)
Washington D.C. (64)
Washington State (558)
West Virginia (3)
Wisconsin (60)
703,403 Results for "national institutes of health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Business
The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development
The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.
May 13, 2024
·
3 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
Press Releases
IVOS Medical Receives Phase II SBIR Award from the National Institutes of Health for $1.9M
January 22, 2025
·
2 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Business
The Foundation for the National Institutes of Health Appoints James W. Down and Perry Steiner to Its Board of Directors
The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.
May 29, 2024
·
3 min read
Biotech Bay
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
Kyverna Therapeutics, Inc. announced the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled “Chimeric antigen receptor T cell therapy for autoimmune disease”.
June 10, 2024
·
5 min read
1 of 70,341
Next
